Medigabinety Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals

Secondary Activities: Pharmacies and Drug Stores | Other Direct Selling Establishments | Internet Publishing and Broadcasting and Web Search Portals | Lessors of Real Estate | Office Administrative Services | Ambulatory Health Care Services | Offices of All Other Miscellaneous Health Practitioners | All Other Miscellaneous Ambulatory Health Care Services

Full name: Medigabinety Sp. z o.o.

Profile Updated: July 29, 2025

Medigabinety Sp. z o.o. is based in Poland. The head office is in Warsaw. It operates in the General Medical and Surgical Hospitals industry. The enterprise was incorporated on April 03, 2020. From the latest financial highlights, Medigabinety Sp. z o.o. reported a net sales revenue increase of 32.83% in 2024. Its’ total assets recorded a negative growth of 9.65%. The net profit margin of Medigabinety Sp. z o.o. increased by 3134.54% in 2024.

Headquarters
Ul. Stefana Batorego 18/108
Warsaw; Mazowieckie; Postal Code: 02-591

Contact Details: Purchase the Medigabinety Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Medigabinety Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Medigabinety Sp. z o.o. report to view the information.

Incorporation Date:

April 03, 2020

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Company Performance

Financial values in the chart are available after Medigabinety Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

32.83%▲

Total operating revenue

23.52%▲

Operating profit (EBIT)

84.56%▲

EBITDA

84.56%▲

Net Profit (Loss) for the Period

81.42%▲

Total Assets

-9.65%▼

Total Equity

-6.74%▼

Operating Profit Margin (ROS)

3292.77%▲

Net Profit Margin

3134.54%▲

Return on Equity (ROE)

-29.97%▼

Debt/Equity

6.11%▲

Similar companies